MUTANT CALRETICULIN FOR THE DIAGNOSIS OF MYELOID MALIGNANCIES
摘要
The present invention relates to a method for diagnosing myeloid malignancy comprising determining the presence of a mutant allele of the calreticulin gene. Also genomic sequences, cDNA sequences, mRNA sequences and protein sequences of the mutant calreticulin are subject of the present invention. Further, the invention relates to medical uses of inhibitors of mutant calreticulin.
申请公布号
SG11201601193T(A)
申请公布日期
2016.04.28
申请号
SGT11201601193
申请日期
2014.09.15
申请人
CEMM - FORSCHUNGSZENTRUM FÜR MOLEKULARE MEDIZIN GMBH